Business Wire

MILREM-ROBOTICS

14.9.2021 09:02:12 CEST | Business Wire | Press release

Share
Milrem Robotics to Develop the Nordic Robotic Wingman With Kongsberg Defence & Aerospace

The leading European robotics and autonomous systems developer Milrem Robotics is to develop a new Robotic Combat Vehicle (RCV) named Nordic Robotic Wingman in cooperation with the leading technology and defence supplier, Kongsberg Defence & Aerospace (KONGSBERG).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005044/en/

The Nordic Robotic Wingman will be based on Milrem Robotics’ state of the art Type-X RCV and KONGSBERG’s latest and best PROTECTOR Remote Turrets (RT) that will be chosen specifically to meet the particular needs of various end-users.

The first Nordic Robotic Wingman concept will be exhibited at DSEI 2021 in London.

“Milrem Robotics and KONGSBERG have agreed to jointly continue the development of the Type-X RCV by integrating KONGSBERG’s systems to address the requirements of many countries interested in this type of technology, especially the Nordics and Western Europe, but also the US,” said Sverker Svärdby, Managing Director of Milrem Robotics’ Sweden. “Combining our knowledge of robotic combat vehicles and KONGSBERG’s wide range of systems and extensive expertise in defence systems development, we are capable of providing world-class systems based on customer needs,” Svärdby added.

The Type-X provides equal or overmatching firepower and tactical usage to a unit equipped with Infantry Fighting vehicles and gives mechanized units the means to breach enemy defensive positions with minimal risk to own troops. It can be fitted with a cannon up to 50 mm, anti-tank missiles and a tethered drone for continuous situational awareness.

“KONGSBERG has a family of unmanned PROTECTOR Remote Weapon Systems, ranging from the smallest RS2 Remote Weapon Station to the true Infantry Fighting Vehicle turret RT60 with Anti-Tank Guided Missile capability. The systems have a common software baseline, are easy to integrate and provide proven capabilities for the warfighter. KONGSBERG’s solution provides the operator with situational awareness and a safe and secure network-based fire control that is fielded with the Norwegian Army and in delivery to the US Army’s Robotic Combat Vehicle program,” said Arne Gjennestad, Vice President of Marketing & Sales, KONGSBERG.

Milrem Robotics’ Type-X is equipped with intelligent functions such as follow-me, waypoint navigation and obstacle detection with Artificial Intelligence being part of the algorithms. With the Type-X Milrem Robotics also introduces a feature called Indirect Drive that allows remote controlled operations on higher speeds.

Milrem Robotics is the European leading robotics and autonomous systems developer and systems integrator with offices in Estonia, Sweden, Finland and shortly in the Netherlands.

The company leads the iMUGS Consortium that was awarded 30,6 MEUR from the European Commission’s European Defence Industrial Development Programme (EDIDP) to develop a European standardized unmanned ground system (UGS).

Kongsberg Defence & Aerospace is a leading supplier of defence products and systems for command and control, surveillance, space, tactical communications, remote weapon stations and missiles, as well as advanced composites, engineering products and repair and overhaul services for aircraft and helicopters.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye